Arcus Biosciences, Inc. (NYSE:RCUS) is held by 202 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 31 Mar, 2026 | 31,424,760 | 0 | 0.00% | $678,774,816.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 15,226,475 | 228,584 | 1.52% | $328,891,861.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 6,089,516 | 905,007 | 17.46% | $131,533,546.00 |
| State Street Corp | 31 Mar, 2026 | 5,412,901 | 835,932 | 18.26% | $116,918,662.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 5,030,993 | -157,865 | -3.04% | $108,669,449.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 4,272,056 | 4,272,056 | 0.00% | $92,276,410.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,856,725 | 3,856,725 | 0.00% | $83,305,260.00 |
| Woodline Partners LP | 31 Mar, 2026 | 3,777,798 | 8,010 | 0.21% | $81,600,437.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 3,761,437 | 373,643 | 11.03% | $81,247,040.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 3,007,077 | 0 | 0.00% | $64,952,863.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,252,367 | 345,022 | 18.09% | $48,659,380.00 |
| Fisher Asset Management, LLC | 31 Mar, 2026 | 2,190,404 | 240,616 | 12.34% | $47,312,724.00 |
| SAMLYN CAPITAL, LLC | 31 Mar, 2026 | 1,908,412 | 304,142 | 18.96% | $41,221,700.00 |
| BNP Paribas Asset Management Holding S.A. | 31 Mar, 2026 | 1,654,754 | -32,620 | -1.93% | $35,742,686.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 1,426,223 | -97,934 | -6.43% | $30,801,780.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 1,329,935 | 1,225,234 | 1,170.22% | $28,726,596.00 |
| Parkman Healthcare Partners LLC | 31 Mar, 2026 | 1,207,274 | 1,207,274 | 0.00% | $26,077,118.00 |
| Logos Global Management LP | 31 Mar, 2026 | 1,200,000 | 1,200,000 | 0.00% | $25,920,000.00 |
| FMR LLC | 31 Mar, 2026 | 1,165,252 | 30,074 | 2.65% | $25,169,435.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,113,526 | -97,228 | -8.03% | $24,052,175.00 |